Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Balance Sheet
ASSETS
Non-Current Assets 9552044849 10773806085 11400824643
Property Plant & Equipment 6364824546 6662947875 7315630085
Deferred Tax Assets
Investment- Long Term 145157800 145157800 185157800
Investment in Marketable Securities
Investment - Associate Undertakings 3039213986 3958738620 3900036758
Pre-operating/Preliminary Expenses 2848517 6961790
Check 0 0 0
Net Income
Change in Net Working Capital
Non Cash Expenses
12296.22 12781.04
3817209875 4615536767 5089203581 6144784666 7208225885 10796568677 12296218982 12781036198
453850083 419629753 377846808 245133874 293730506 657143316 1093575634 1768094011
11649.64 12079.94
321469720 1091148736 0 0 0 0 0 0
2504841900 1717273322 1108757914 1161185776 885185428 2378929958 21386290 3131975363
429307393 747628997 981187836 2162717207 3892185634 8522555131 15768683854 16980412765
0 0 0 0 0 0 0 0
0 0 -1500000 0
0 0 0 0
0 0 150000000 0
0 0 150000000 150000000
-123904667
-10000000 10000000 10000000 10000000 20000000
-34166580 28472150 0 0
100000
-109290273 -38900553 4247563 -21651371 -218811753
-1448348253 787568578 608515408 -52427862 276000348
-253237104 -386806375 -3632649184 -1363637040 -71299346
125126871 0 0 6598771 6863121 10983571 57295584 291936032
154278638 211354562 176943100 151443710 158179691 253117331 587461554 955580148
80535552 91315885 96904124 128006027 158561700 47172498 295466575 295896484
0 0 0 0 0
0 0 0 0 0
3132081958 3131980451 3132005678 3132437082 3132253082
23511901473.2429 27596990801.8727 32496952976.932 38110548975.8086 45393997958.0133
0 0 0 0 0
0 0
0 0
0 0
0 0
0 0
4661772.46308167 20808.5924875205 138511.879331646 159295.504505888 183492.092483773
-2654607924 -2734246161.72 -2816273546.5716 -2900761752.96875 -2987784605.55781
Time Line
PV of FCFF
Cost of Equity
Cost of Debt
WACC 4.3%
Terminal Growth Rate 3%
PV of the Firm 523875698885.2
Int. Bearing Debt 54661772.4630817
Non Controlling Interest 14135541.0559
Cash & Cash Equivalents 23511901473.2429
PV of Equity 547318803044.9
Total No. of Shares 789,008,466.0
Per Value of Stocks 693.68
Return Calculation
Current Price
Target Price (BDT)
Capital Gain
Dividend Yield (Y-1)
Return (%)
Target Price
2010-11A 2011-12A 2012-13A 2013-14A 2014-15A 2015-16A
3,626,080,042 4,395,056,969 4,842,473,717 5,844,345,824 6,828,430,823 10,251,406,195
2719560031.5 3296292726.75 3631855287.75 4383259368 5121323117.25 7688554646.25
1,088,177,146 1,234,178,338 1,228,124,891 1,181,229,254 1,708,465,394 2,010,881,334
362392470 -16672794 331711252 -1050006487 289463829 809522323
2,476,083,845 2,949,747,382 1,786,775,567 2,234,360,509 2,680,026,455 2,657,669,483
Pharmaceuticals
247.10-335
789,008,466.0
65.6%
517,589,553.7
10.1%
35.6%
34.4%
19.9%
2014-15A 2015-16A 2016-17A 2017-18A
26,684,573,116 33,073,760,572 36,543,140,106 39,653,831,638
11,741,702,961 15,991,423,915 18,268,281,192 19,564,011,725
7,208,225,885 10,796,568,677 12,296,218,982 12,781,036,198
5,186,436,869 8,286,543,555 9,719,176,205 10,490,891,282
35,191,156,263 44,303,769,450 52,531,052,249 61,273,001,535
31,093,302,284 40,555,055,362 49,027,700,210 57,816,566,831
2015-16A 2016-17A 2017-18A
48% 50% 49%
33% 34% 32%
25% 27% 26%
2015-16A 2016-17A 2017-18A
24% 10% 9%
36% 14% 7%
50% 14% 4%
60% 17% 8%
2015-16A 2016-17A 2017-18A
14.8 15.5 15.7
55.0 66.5 78.4
2015-16A 2016-17A 2017-18A
18.2x 17.3x 17.0x
4.9x 4.0x 3.4x
267.8
389.9
45.6%
1.3%
46.9%
14% 14%
14% 13%
2021-22E 2022-23E
10,724,431,226 10,856,476,370
8043323419.1546 8142357277.64081
6,446,704,336 8,963,721,943
318591009.011776 366984184.967545
9,063,120,321 10,422,588,370
5,108,316,425 6,316,506,666
502769366208
5,108,316,425 509,085,872,874
3.08 4.08
5108316425.20437 509085872873.60
2007-08A 2008-09A 2009-10A 2010-11A
Current Asset (without Cash & STI) 3,850,526,930 3,186,813,738 3,457,357,439 5,198,505,701
Inventories 2,524,072,437 2,272,542,160 2,408,205,461 2,956,395,789
Spares & Accessories 105,484,833 132,988,909 166,523,457 222,563,449
Trade Debtors 890,994,987 477,562,002 511,977,702 1,421,567,342
Advances,Deposits and Prepayments 329,974,673 303,720,667 370,650,819 597,979,121
Current Liabilitiy (without STD & Cur. Maturit 912,897,146 835,824,025 711,310,069 2,090,065,861
Trade Creditors 233,405,650 127,550,930 103,428,870 1,208,102,997
Liabilities for Expense 236,247,055 93,613,902 61,271,985 90,485,689
Liabilities for other Finance 443,244,441 614,659,193 546,609,214 791,477,175
As a % of Revenue
Current Asset (without Cash & STI) 32.02% 23.46% 23.00% 26.84%
Inventories 20.99% 16.73% 16.02% 15.27%
Spares & Supplies 0.88% 0.98% 1.11% 1.15%
Trade Debtors 7.41% 3.52% 3.41% 7.34%
Advances,Deposits and Prepayments 2.74% 2.24% 2.47% 3.09%
Current Liabilitiy (without STD & Cur. Maturit 7.59% 6.15% 4.73% 10.79%
Trade Creditors 1.94% 0.94% 0.69% 6.24%
Liabilities for Expense 1.96% 0.69% 0.41% 0.47%
Liabilities for other Finance 3.69% 4.52% 3.64% 4.09%
Short Term Bank Loans as a % of Working Capi 108.03% 72.83% 32.04% 93.75%
Short Term Loans as a % of Working Capital 0.00% 0.00% 0.00% 0.00%
Current Portion as a % of LTB 125.23% 100.80% 122.22%
Cost
Beginning Cost 7,569,779,815 8,667,315,528 9,324,737,035 11,373,590,553
Adjustment due to Merger -812,269,240
Addition 1,097,535,713 1,469,690,747 2,048,853,518 2,440,592,268
Disposal
Sales/Transfer during the Year
Ending Cost 8,667,315,528 9,324,737,035 11,373,590,553 13,814,182,821
Depreciation
Beginning Value
Adjustment due to Merger
Addition: Charged During the Year
Disposal
Sales/Transfer during the Year
Intangible Assets
Net Intangible Asset
Amortization
1,091,148,736
747,628,997 981,187,836 2,162,717,207 3,892,185,634 8,522,555,131 15,768,683,854 16,980,412,765
804,638,100 686,985,768 844,360,472 879,249,484 1,071,735,442 1,938,209,078 2,480,068,125
1,717,273,322 1,108,757,914 1,161,185,776 885,185,428 2,378,929,958 21,386,290 3,131,975,363
229.70% 113.00% 53.69% 22.74% 27.91% 0.14% 18.44%
6518329427.55 7588329001.5933
3% 3% 3% 3% 3%
0 0
2734246161.72 2816273546.5716 2900761752.969 2987784605.55781 3077418143.72455
0 0
Profitability
Gross Profit 37.98% 40.70% 43.32% 39.42%
Gross Profit without Dep 42.88% 46.02% 48.71% 44.62%
Operating Profit 21.31% 24.77% 25.64% 22.49%
EBIT (OP-WPPF) 15.68% 14.77% 16.46% 15.80%
EBITDA Margin 27.32% 30.60% 31.24% 27.77%
Net Profit 14.60% 17.89% 18.26% 16.68%
Return of Asset 10.23% 14.19% 14.44% 12.57%
Return of Equity 16.21% 19.36% 18.30% 17.73%
Effeciency
Inventory Turnover 140.7462203 118.280111 119.55 104.93
Receivable Turnover 30.81490806 14.7392953 14.41 30.57
Payable Turnover 13.01506349 6.63870549 5.13 42.88
Total Asset Turnover 0.700865247 0.79346283 0.79 0.75
Growth
Gross Revenue 12.98% 10.66% 28.82%
Net Revenue 12.06% 9.68% 30.87%
Opex 7.11% 21.66% 25.35%
Ope. Profit 30.25% 13.55% 14.77%
Net Profit 37.32% 11.95% 19.53%
NAV
Restated EPS
2011-12A 2012-13A 2013-14A 2014-15A 2015-16A 2016-17A 2017-18A
15.51 16.90
6859450000
2018-19E 2019-20E
26.32% 26.32%
14.21% 14.48%
12.33% 14.48%
38.55% 15.04%
-19.58% 9.81%
-15.76% 10.60%
As a % of Total Revenue
Check- COGS
Raw Materials Purchase
Raw Materials Closing Stock
Packaging Materials Purchase
Packaging Materials Closing Stock
Factory Overhead
Work in Progress (Closing)
Finished Goods (Purchase)
Finished Goods (Closing)
Cost of Physician Sample
depreciation
48.87%
10.46%
1.53%
1.90%
16.74%
Price 266.3
P/E 22
NAV 46662876378
NAVPS 63.28
P/NAV 4.2082806574
Date
JAN 16,2019
Average Market Price of Similar Stock
393.78
Cost of Equity 4.3%
Debt 0
Equity 7373910900
Total market value of the firm’s financing (equity and debt) 7373910900
WACC 4.3%
16818750
377.5
6349078125
142909410
326089784
468,999,194
183199401
6,634,877,918
219238363
21055157
240293520
27.6115557257